Níveis Séricos de Glicogênio Sintase 3 Beta: Um Marcador Promissor para Pacientes com Insuficiência Cardíaca
Open Access
- 1 January 2024
- journal article
- editorial
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 121 (11) , e20240684
Abstract
A insuficiência cardíaca (IC) envolve inflamação sistêmica e alterações metabólicas. A prevalência está aumentando devido a melhorias nos tratamentos de IC e maior expectativa de vida na população. Além disso, a abordagem diagnóstica de pacientes com IC aumentou significativamente com o desenvolvimento de novos algoritmos para promover o diagnóstico mais precoce. O uso cuidadoso de biomarcadores pode ajudar a refinar o diagnóstico e o tratamento e melhorar ainda mais o prognóstico de pacientes com IC. O termo “biomarcador” (de marcadorKeywords
This publication has 13 references indexed in Scilit:
- 2024 Update in Heart FailureESC Heart Failure, 2024
- Determination of Serum Glycogen Synthase 3 Beta Levels in Patients with Heart Failure, a Novel Marker for Diagnosis and Defining Disease Severity?Arquivos Brasileiros de Cardiologia, 2024
- Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targetsCardiovascular Research, 2022
- Uncoupling between intravascular and distending pressures leads to underestimation of circulatory congestion in obesityEuropean Journal of Heart Failure, 2021
- Role of GSK-3 in Cardiac Health: Focusing on Cardiac Remodeling and Heart FailureCurrent Drug Targets, 2021
- Biomarkers for the diagnosis and management of heart failureHeart Failure Reviews, 2021
- Inhibition of Glycogen Synthase Kinase-3β Attenuates Organ Injury and Dysfunction Associated With Liver Ischemia-Reperfusion and Thermal Injury in the RatShock, 2015
- Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysisBritish Journal of Pharmacology, 2008
- GSK3 alpha and GSK3 beta are necessary for axon formationFEBS Letters, 2007
- Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart FailureCirculation, 2001